VAMP8 and breast cancer: Our identification of Vamp8 as an interactor of Rab17 and the fact that Vamp8 was downregulated in Rab17-depleted cells prompted us to determine whether Vamp8 contributes to the ability of Rab17 to function as a suppressor of breast cancer cell invasiveness.